Active ingredient
Risankizumab NDC Codes
Risankizumab is an active ingredient in 6 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Skyrizi
- Labelers
- AbbVie Inc.
- Strengths
- Risankizumab 180 mg/1.2mL; Risankizumab 150 mg/mL; Risankizumab 55 mg/.37mL; Risankizumab 600 mg/10mL
- Dosage forms
- Injection, Injection, Solution
- Routes
- Subcutaneous, Intravenous
- Drug classes (FDA established)
- Interleukin-23 Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 10
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Skyrizirisankizumab-rzaa | Risankizumab 55 mg/.37mL | Injection, SolutionSubcutaneous | AbbVie Inc. | 0074-4059 | 00074-4059-0100074-4059-71 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 180 mg/1.2mL | InjectionSubcutaneous | AbbVie Inc. | 0074-8300 | 00074-8300-01 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 180 mg/1.2mL | InjectionSubcutaneous | AbbVie Inc. | 0074-8350 | 00074-8350-01 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 600 mg/10mL | InjectionIntravenous | AbbVie Inc. | 0074-5015 | 00074-5015-0100074-5015-02 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 150 mg/mL | InjectionSubcutaneous | AbbVie Inc. | 0074-2100 | 00074-2100-0100074-2100-70 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 150 mg/mL | InjectionSubcutaneous | AbbVie Inc. | 0074-1050 | 00074-1050-0100074-1050-70 | — |
Risankizumab: common questions
- Which drugs contain Risankizumab?
- Skyrizi.
- Is there a J-code for Risankizumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.